MEDI-8968

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameMEDI-8968
Drug Alias NameAMG-108MEDI-8968Anti-IL-1R MAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-1 alpha inhibitors
TargetsInterleukin-1 alpha
Therapy Area/IndicationsDiabetes MellitusPulmonary Disease, Chronic ObstructiveOsteoarthritis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcMedimmune LlcAmgen Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusPulmonary Disease, Chronic ObstructiveOsteoarthritis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A